Rigel Pharmaceuticals Inc (RIGL) — Cash Flow Reinvestment Rate
Rigel Pharmaceuticals Inc (RIGL) has a Cash Flow Reinvestment Rate of 2.93x as of March 2026, reinvesting $7.97 Million (capex $0.00 plus investments $-7.97 Million) from operating cash flow of $2.73 Million. Explore Rigel Pharmaceuticals Inc (RIGL) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Rigel Pharmaceuticals Inc Cash Flow Reinvestment Rate (2010–2025)
Historical reinvestment intensity for Rigel Pharmaceuticals Inc across 4 annual periods. Also explore Rigel Pharmaceuticals Inc (RIGL) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Rigel Pharmaceuticals Inc (2010–2025)
Year-by-year capital reinvestment analysis for Rigel Pharmaceuticals Inc. For live market cap and broader valuation context, see market value of Rigel Pharmaceuticals Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.22x | $92.36 Million | $75.66 Million | $0.00 | ▲ +748.9% |
| 2024 | 0.14x | $4.53 Million | $31.47 Million | $396.00K | ▼ -98.9% |
| 2021 | 13.62x | $80.04 Million | $5.88 Million | $627.00K | ▲ +17778.1% |
| 2010 | 0.08x | $3.56 Million | $46.74 Million | $3.56 Million | — |